-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Smoking Cessation Drug Details: Psilocybin is under investigation for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Bupropion Hydrochloride + Dextromethorphan) ER in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Bupropion Hydrochloride + Dextromethorphan) ER in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Bupropion Hydrochloride + Dextromethorphan) ER in Smoking Cessation...
-
Product Insights
Smoking Cessation – Drugs In Development, 2023
Global Markets Direct’s, ‘Smoking Cessation - Drugs In Development, 2023’, provides an overview of the Smoking Cessation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Smoking Cessation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QN-01 in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QN-01 in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QN-01 in Smoking Cessation Drug Details: QN-01 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBP-0069330 in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBP-0069330 in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBP-0069330 in Smoking Cessation Drug Details: SBP-0069330 is under development for the...
-
Product Insights
NewLikelihood of Approval Analysis for Squamous Non-Small Cell Lung Carcinoma
Overview How likely is it that the drugs in Squamous Non-Small Cell Lung Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Squamous Non-Small Cell Lung Carcinoma Overview Squamous cell carcinoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-527 in Smoking Cessation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OMS-527 in Smoking Cessation Drug Details: OMS-527 is under development for the treatment of movement...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-150 in Smoking Cessation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Smoking Cessation Drug Details: PT-150 is under development for the treatment of opioid...
-
Product Insights
NewLikelihood of Approval Analysis for Lung Disease
Overview How likely is it that the drugs in Lung Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lung Disease Overview Lung diseases are infections or disorders that affect the...
-
Product Insights
NewLikelihood of Approval Analysis for Cough
Overview How likely is it that the drugs in Cough will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cough Overview A cough is a sudden expulsion of air through the large...